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This study aimed to determine the acetylation patterns on histone H3K9/18/23 
and the dimethylation pattern on histone H3K9 during early embryogenesis among 50 
nM Trichostatin A (TSA)-treated iSCNT cat-cow embryos, untreated iSCNT cat-cow 
embryos (control) and bovine in vitro fertilisation (IVF) embryos, because TSA-
treated iSCNT embryos are able to develop into blastocysts. The results show that the 
acetylation levels of H3K9/18/23 in the TSA-treated iSCNT and bovine IVF embryos 
were higher than those in the control embryos at almost all of the examined stages (2 
h post-fusion / post-insemination (PF/PI), pronuclear (PN), two-cell, four-cell and 
eight-cell stages). At 6 h PF/PI the acetylation levels on H3K9/23 in the TSA-treated 
iSCNT and bovine IVF embryos were lower than those in the control, and there was 
no difference in the acetylation levels of H3K18 among the three groups. The 
acetylation levels of H3K9/23 increased either in the TSA-treated iSCNT or and 
bovine IVF embryos increased when those embryos developed to the PN and two-cell 
stages. The dimethylation level of H3K9 in the TSA-treated iSCNT embryos 
resembled that of the bovine IVF embryos at all examined stages (2h PF/PI, 6 h PF/PI 
and PN stages), and these levels were greater than those of the control. This result 
suggests that treatment of iSCNT embryos with TSA modifies the patterns of histone 
acetylation and dimethylation at certain lysine residues in a manner that is comparable 
with that seen in IVF embryos during early embryogenesis.  
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Interspecies somatic cell nuclear transfer (iSCNT) has been developed for the 
purpose of endangered animal conservation as well as for analysing the interactions 
between the donor nucleus and the recipient cytoplasm (Yamochi et al., 2012); 
however, incomplete nuclear reprogramming, a low blastocyst rate, and abnormal 
epigenetic reprogramming are still major problems of this technique (Shi et al., 2008; 
Wu et al., 2011). Histone modifications play important roles in cell growth, cell cycle 
control, development, differentiation and survival during embryonic development 
(Gray and Dangond, 2006; Lee et al., 2010) through the binding interactions of the 
acetyl or methyl groups in the amino-terminal tail of core histones (Suteevun et al., 
2006). Cloned embryos usually show higher rate of abnormal patterns of histone 
modification on developmental embryos (Liu et al., 2012; Wu et al., 2011), therefore, 
the normal patterns of histone modification are thought to be required for the 
development of cloned embryos (Maalouf et al., 2009; Shi et al., 2008; Zhao et al., 
2009). Several researchers have investigated the mechanism underlying aberrant 
epigenetic information, which can lead to the deregulation of a number of important 
gene  expressions in cloned embryos (Maalouf et al., 2008). For example, to adjust the 
patterns of histone acetylation in cloned embryos to be similar to those of normal 
embryos, the treatment of early stage embryos with a histone deacetylase (HDAC) 
inhibitor, such as Trichostatin A (TSA), has been suggested (Lee et al., 2010).  
The deacetylation of core histones by HDAC leads to transcriptional 
repression (Pazin and Kadonaga, 1997) by catalysing the removal of acetyl groups 
from the epsilon-amino groups of distinct lysine residues in the amino-terminal tail of 
core histones (Finnin et al., 1999; Tribus et al., 2005). The HDAC inhibitors TSA and 
n-butyrate can cause the accumulation of highly acetylated histone species within cells, 
resulting in a variety of phenotypic changes (Liu et al., 2012; Nakajima et al., 1998). 
The ability of TSA to increase the in vitro embryo developmental rate has been 
demonstrated in a number of SCNT studies, e.g. in pigs (Li et al., 2008; Zhang et al., 
2007), mice (Kishigami et al., 2006) and cattle (Sawai et al., 2012). Acetylation at 
lysine 9 and lysine 18 of histone H3 (H3K9ac and H3K18ac) has crucial roles in 
activating gene transcription (Pham et al., 2007; Sawai et al., 2012). Concurrently, the 
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acetylation at lysine 23 of histone H3 (H3K23ac) can regulate the recognition of the 
chromodomain of polycomb proteins (Robin et al., 2007), which is essential for gene 
expression during development in mammals (Ku et al., 2008). Moreover, H3K18ac 
and H3K23ac have been considered to play an important role for ordered oocyte 
meiosis (Xue et al., 2010); however, very few studies have investigated the dynamics 
of several acetylated lysine residues in iSCNT embryos during early embryogenesis 
after fusion (Gómez et al., 2011; Shi et al., 2008). Additionally, the methylation of 
lysine residues displays the highest degree of complexity among known covalent 
histone modifications (McGraw et al., 2003). Histone lysine methylation has different 
effects depending on the residue that is methylated. The dimethylation on K9 of 
histone H3 (H3K9me2) and tri-methylation on K27 of histone H3 (H3K27me3) are 
generally correlated with transcriptional repression (Jin et al., 2011; Robin et al., 
2007). In contrast, tri-methylation on K4 and K36 of histone H3 (H3K4me3 and 
H3K36me3) is associated with gene activation (Jin et al., 2011). 
Nuclei from somatic cells of the domestic cat could be reprogrammed when 
transferred into bovine oocytes; however, the embryos were not able to develop 
beyond the eight-cell stage without any treatment for epigenetic modification 
(Thongphakdee et al., 2008). This developmental block might be caused by aberrant 
epigenetic patterns before embryonic genome activation, the most important event 
during early development for embryo viability (Meirelles et al., 2004). Furthermore, 
genomic activation among the embryo species differs in timing; embryonic genomic 
activation occurs at the five- to eight-cell stage in the domestic cat (Hoffert et al., 
1997) and the eight- to sixteen-cell stage in the cow (Camous et al., 1986). Previously, 
we showed that the treatment of iSCNT cat-cow embryos with TSA at concentration 
50 nM for 24 h after fusion could support embryo development until the blastocyst 
stage, whereas none of the un-treated iSCNT cat embryos developed beyond the 
eight- to- sixteen-cell stage (Wittayarat et al., 2013). Therefore, the assessment of the 
covalent patterns of acetylation and methylation on histone H3 might be valuable to 
determine its role on early iSCNT cloned cat embryo development to improve the 
culture condition of the embryos. In the present study, we demonstrate the covalent 
patterns of H3K9/18/23ac and H3K9me2 in iSCNT cat embryos treated with 50 nM 
TSA compared to un-treated iSCNT embryos (control) and in vitro fertilised bovine 
embryos during early embryogenesis, including before cleavage. 
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Materials and Methods  
 
Preparation of recipient oocytes and domestic cat somatic cells for nuclear transfer  
Bovine oocytes were matured according to procedures described previously by 
Mori et al. (Mori et al., 2002). Cumulus-oocyte complexes (COCs) were cultured in 
maturation medium that consisted of TCM 199 with Earle’s salts (Invitrogen, 
Carlsbad, CA, USA) supplemented with 0.05 g of taurine (Sigma-Aldrich, St. Louis, 
MO, USA), 0.02 IU/mL of follicle stimulating hormone (FSH; Kawasaki Mitaka 
Seiyaku K.K., Kawasaki, Japan), 5% foetal bovine serum (FBS; Invitrogen), 40 
µg/mL of epidermal growth factor (EGF; Sigma-Aldrich), and 50 µg/mL of 
gentamicin (Sigma-Aldrich) for 22 h at 38.5°C in a humidified atmosphere containing 
5% CO2. 
Domestic cat fibroblast cells were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM; Invitrogen) supplemented with 20% (v/v) FBS and 50 μg/mL of 
gentamicin at 37°C in a humidified atmosphere containing 5% CO2. Once the 
fibroblast cells reached complete confluence, the cells were trypsinised with 0.25% 
(w/v) trypsin (Invitrogen). Afterwards, the cells were either frozen for storage or used 
as donors for nuclear transfer (passage 3-6) (Kaedei et al., 2010).  
 
SCNT, activation, in vitro culture of embryos, and TSA treatment 
SCNT was conducted according to the methods previously described by 
Taniguchi et al. (Taniguchi et al., 2007). Briefly, the zona pellucida above the first 
polar body was cut with a glass needle and a small volume of cytoplasm was then 
squeezed out (the metaphase spindle and first polar body were visualised after 
incubating the oocytes in 3 μg/mL of Hoechst 33342 (Sigma-Aldrich)). A single cat 
cell was then introduced into the perivitelline space of the enucleated oocyte. The 
couplets were fused and activated simultaneously with a single DC pulse of 2.3 
kV/cm for 30 μs delivered by two electrode needles (LF101; Nepa Gene Co. Ltd., 
Chiba, Japan) connected to a micromanipulator (MO-202D; Narishige Co. Ltd., 
Tokyo, Japan). The fused couplets were cultured for 5 h in a modified synthetic 
oviduct fluid (mSOF) medium (Kwun et al., 2003) supplemented with 10 µg/mL of 
cycloheximide (Sigma-Aldrich) and 50 nM TSA (Wako Pure Chemical Industries. 
Ltd., Tokyo, Japan). The fused embryos were then transferred to mSOF medium 
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containing 50 nM TSA and cultured for an additional 19 h. After 24 h of TSA 
treatment, the embryos were cultured in mSOF medium supplemented with 4 mg/mL 
of bovine serum albumin (BSA; Sigma-Aldrich) for 2 days at 38.5°C in a humidified 
atmosphere of 5% CO2, 5% O2 and 90%N2. The embryos cultured without TSA 
treatment served as the control. To determine the covalent patterns of H3K9/18/23ac 
and H3K9me2, the embryos were collected at 2 h post-fusion (PF), 6 h PF, 20 h PF 
(pronuclear; PN), 24 h PF (two-cell), and day 3 of culture (four- and eight-cell). 
To compare with naturally fertilised embryos, in vitro fertilised (IVF) bovine 
embryos were used. IVF was carried out according to the method described by 
Taniguchi et al. (Taniguchi et al., 2007). The PN and two-cell stage embryos were 
collected at 20 h and 24 h post-insemination (PI), respectively, and the four- and 
eight-cell stage embryos were collected at 48 h PI for fluorescent immunodetection.  
 
Fluorescent immunodetection of H3K9ac, H3K18ac, H3K23ac and H3K9me2 in 
iSCNT cloned cat embryos 
Fluorescent immunodetection was processed according to the protocol 
described in our previous study (Wittayarat et al., 2013). The embryos at 2 h PF/PI, 6 
h PF/PI, PN, two-cell, four-cell and eight-cell stages from the 50 nM TSA-treated, 
control and IVF groups were subjected to H3K9ac, H3K18ac and H3K23ac 
fluorescent immunodetection. Simultaneously, the embryos at 2 h PF/PI, 6 h PF/PI 
and PN stages were used for H3K9me2 fluorescent immunodetection because the 
change of the H3K9/18/23ac was high during these periods.  
All of the following steps were performed at room temperature (RT) and all of 
the solutions were prepared in 10% FBS/phosphate-buffered saline (PBS), unless 
otherwise indicated. The embryos were fixed in 3.7% paraformaldehyde/PBS 
overnight at 4ºC, permeabilised with 0.1% TritonX-100 (Sigma-Aldrich)/PBS for 40 
min and then stored in 1% (w/v) BSA/PBS overnight at 4°C. The permeabilised 
embryos were incubated in 10% goat serum (Nichirei, Tokyo, Japan)/PBS for 1 h to 
block non-specific binding before incubated with the following primary antibodies; 
rabbit polyclonal acetyl-histone H3K9 antibody (5 μg/ml), H3K18 antibody (1.4 
μg/ml), H3K23 antibody (2.7 μg/ml), rabbit polyclonal di-methyl-histone H3K9 
antibody (5 μg/ml) or rabbit polyclonal histone H3 antibody (5 μg/ml), (Cell 
Signaling Technology Inc., Danvers, MA, USA) respectively in a moisture chamber 
overnight at RT. Normal rabbit immunoglobulin G (IgG; Dako, Kyoto, Japan) 
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adjusted to the same concentration of primary antibodies, was used as the negative 
control. The embryos were subsequently incubated in 4 μg/ml of Alexa 594-
conjugated goat anti-rabbit IgG secondary antibody (Invitrogen) for 1 h in a moisture 
chamber before counterstained with 5 μg/ml of 4’, 6-diamidino-2-phenylindole 
(DAPI; Invitrogen) for 10 min in the dark. The images were obtained using a 
fluorescence microscope (Nikon Eclipse 80i; Nikon, Tokyo, Japan) equipped with a 
Nikon DS-Ri1 digital camera (Nikon). The images were then acquired using the NIS-
Element D 3.1 (Nikon) imaging software package running on a work station (Dell 
Optiplex 960 PC; Dell Inc., Austin, TX, USA). 
 
Semi-quantification of fluorescence intensities in the embryos 
The fluorescence images of each nucleus within an embryo were taken under 
the following conditions: Alexa Fluor 594 dye, DAPI, and in the bright field. The 
signal intensities of fluorescence from acetylated histone H3K9/18/23ac, dimethylated 
histone H3K9me2, histone H3 and DAPI-nucleic acid staining were measured 
automatically using imaging software under the area of the nucleus by manually 
outlining a limited area of each nucleus within an embryo, except for overlapping or 
folded nuclei. The fluorescence intensities of the embryonic cytoplasm and 
background were quantified using the same method. The mean intensity in each 
examined nucleus was recorded. The relative intensity levels of H3K9/18/23ac and 





The relative intensity levels of histone H3 in each nucleus were also calculated using 
the same formula. Subsequently, the average values of relative intensity levels of 
H3K9/18/23ac, H3K9me2 and histone H3 in each embryo were calculated. These 
average values of each embryo were used for additional calculations to ascertain the 
average value of the relative intensity levels of H3 K9/18/23ac, H3K9me2 and histone 
H3 in each treatment. The data compensation, in each treatment, during the 
experiments was performed using the average value of the relative intensity levels of 
H3K9/18/23ac, H3K9me2 and histone H3 in the control samples without TSA 
treatment. 
Relative intensity 
in one nucleus = 
    H3K9/18/23ac or H3K9me2 (Mean intensity of nucleus 
- mean intensity of cytoplasm) 





 The percentage data of the intensity levels of H3K9/18/23ac, H3K9me2 and 
histone H3 in the embryos were subjected to arc-sin transformation before analysis of 
variance (ANOVA). The transformed data were tested by the Kruskal–Wallis test, 
followed by Fisher’s protected least significant difference (PLSD) post hoc test. 




All of the nuclei of the iSCNT cloned cat embryos and bovine IVF at any of the 
examined stages showed positive immuno-reactivity in acetyl-histone H3K9, H3K18, 
H3K23 and di-methyl-histone H3K9, irrespective of the TSA treatment (Figs. 1A-D). 
The levels of histone H3 in the embryos were similar in all of the embryonic stages 
among the three groups (control, TSA treated and IVF) (Figs. 2A-D). No differences 
were found in the histone H3 levels in the embryos among the embryonic stages, 
irrespective of the TSA treatment (Figs. 1E, 2E).  
 
Characterisation of H3K9ac, H3K18ac and H3K23ac in iSCNT cat embryos with or 
without treatment with 50 nM TSA post-fusion for 24 h in comparison with bovine 
IVF embryos  
The levels of H3K9/18/23ac in TSA-treated iSCNT embryos, un-treated 
iSCNT (control) embryos and bovine IVF embryos were evaluated (Figs.1A-C, 2A-C). 
The fluorescence intensities in H3K9ac of the control embryos were significantly 
lower than those of the TSA-treated iSCNT embryos in almost all of the examined 
stages (p < 0.05) (Figs. 1A, 2A) except for 6 h PF, where the levels of H3K9ac in the 
TSA-treated iSCNT embryos (0.99 ± 0.05) were significantly lower than those of the 
control embryos (2.82 ± 0.17). The nuclear fluorescence intensities of H3K9ac in the 
TSA-treated iSCNT embryos at PN, four- and eight-cell stages did not show any 
significant difference compared to those of the bovine IVF embryos at the same stage. 
A significantly higher (p < 0.05) intensity of H3K9ac was observed in the TSA-
treated iSCNT embryos at the two-cell stage, whereas, an apparently lower (p < 0.05) 
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intensity of acetylation at this residue was found either at 2 h PF or 6 h PF compared 
to the bovine IVF embryos. 
The signal intensities of H3K18ac in the TSA-treated iSCNT embryos and 
bovine IVF embryos were also significantly higher than those of the control embryos 
at almost all of the examined stages (p < 0.05) (Figs. 1B, 2B), except for the 6 h PF 
stage where the signal levels were similar among the groups. At the PN stage, the 
nuclear fluorescence intensity of H3K18ac in the TSA-treated iSCNT embryos was 
significantly higher (p < 0.05) than those of the bovine IVF embryos. In contrast, a 
significantly lower intensity (p < 0.05) of H3K18ac was observed at the 2 h PF and 
four-cell stage in the TSA-treated iSCNT embryos compared with the bovine IVF 
embryos.  
For the H3K23ac levels, bovine IVF and TSA-treated iSCNT embryos 
expressed lower levels than the control embryos at the 6 h PF/PI stages (p < 0.05) 
(Figs. 1C, 2C). Additionally, significantly higher signal levels of H3K23ac at the PN 
and eight-cell stages were observed in the TSA-treated iSCNT and bovine IVF 
embryos compared with those of the control embryos (p < 0.05). No significant 
differences were observed in H3K23ac levels among the three groups at the 2 h PF/PI, 
two- and four-cell stages.  
 
Characterisation of H3K9me2 in iSCNT cat embryos with or without treatment of 50 
nM TSA post-fusion for 24 h in comparison with bovine IVF embryos  
 The levels of H3K9me2 were determined in both the iSCNT cat embryos with 
or without (control) treatments with 50 nM TSA and the bovine IVF embryos (Fig. 
1D, 2D). The TSA-treated iSCNT embryos showed significantly higher intensity 
levels of H3K9me2 than those of the control embryos and have resembled that of the 
bovine IVF at all of the examined stages (2 h PF, 6 h PF and PN stages) (p < 0.05) .   
    
Discussion 
In the present study, we investigated the histone modifications on various 
lysine residues in iSCNT embryos both before and after cleavage to understand the 
role of TSA in the improved development of iSCNT cat embryos, because treatment 
with 50 nM TSA after fusion of the couplets between bovine recipient cytoplasts and 
cat donor cells for 24 h is beneficial for development to the blastocyst stage 
(Wittayarat et al., 2013). Maternal and zygotic epigenetic factors play essential roles 
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during the development of a pre-implantation embryo and each stage has its own 
characteristic modified histone profile (Shi and Wu, 2009). In iSCNT embryos, 
somatic cells and zygotic histone modifications should occur in a similar condition as 
those in IVF embryos after their fusion for further development. Here we showed that 
the acetylation levels on H3K9, H3K18 and H3K23 of the TSA-treated embryos were 
modified to similar levels as the bovine IVF embryos, which was significantly 
different from the control (untreated iSCNT) embryos, with the exception of some 
specific stages. The results suggest that the treatment with TSA modified the 
acetylation levels on each lysine residue of the iSCNT cat embryos during early 
development after fusion.  
Interestingly, the modification profile of each residue before pronuclear 
formation differed depending on the timing. At 2 h PF/PI, the acetylation levels of 
both H3K9 and H3K18 in both the TSA-treated embryos and bovine IVF embryos 
were significantly greater than those in the control embryos. Our results regarding 
acetylated H3K9 levels have confirmed the report by Gómez et al. (2011) that TSA 
treatment increased the acetylation levels in interspecies black-footed cat cloned 
embryos at 2 h after SCNT, which is similar to the increase seen in the nuclei of cat 
IVF embryos; however, there were no differences among the groups in the acetylation 
levels of H3K23. Others have suggested that there were differences in the affected 
genes because of the various sites of histone acetylation (Pham et al., 2007; Robin et 
al., 2007; Sawai et al., 2012). Thus, the proposed gene affected by the acetylation of 
H3K23 might be dispensable for embryo development at 2 h PF/PI, because the IVF 
embryo showed the same acetylation levels on this residue as the iSCNT embryos.  
Furthermore, at 6 h PF/PI, the acetylation levels on H3K9 and H3K23 of the 
TSA-treated iSCNT embryos and bovine IVF embryos were significantly lower than 
those of the control embryos, suggesting that repression of the gene expression related 
to these residues might be required at the 6 h PF/PI stage; however, there was a 
different acetylation levels between these two acetylation sites. Of note, the change in 
the acetylation levels of H3K9 include de-acetylation between 2-6 h PF/PI and hyper-
acetylation between 6 h PF/PI to PN formation; however, the acetylation levels of 
H3K23 increased gradually until PN formation and did not reveal any de-acetylation. 
The transient de-acetylation on certain histone lysine residues between 2-6 h PI/PF, 
which has already been reported in cat IVF (Gomez et al., 2011), mouse NT (Kim et 
al., 2003; Rybouchkin et al., 2006; Wang et al., 2007) and rabbit NT (Shi et al., 2008), 
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might be considered a crucial event for further development of the iSCNT embryo. 
This event is possibly associated with a rapid loss of the maturation-promoting factor 
and the mitogen-activated protein kinase activities in the matured metaphase II 
oocytes, as well as to allow the transferred somatic genome to exhibit an acetylation 
level similar to the oocyte chromosomes (Wang et al., 2007). De-acetylation of H3K9 
in the iSCNT embryo might also be important in the nuclear reprogramming process 
and the initiation of the zygotic gene expression program to erase the somatic cell 
memory and create a relatively naive chromatin state, similar to the mouse NT and 
Rabbit NT (Kim et al., 2003; Shi et al., 2008); however, the acetylation level of 
H3K18 was quite high in all of the groups at the 6 h PF/PI stage. The gene expression 
related to the H3K18 residue would be promoted in all of the embryo groups, and the 
acetylation level of this residue at the 6 h PF/PI stage was not affected by the TSA 
treatment. These results suggest that histone deacetylation at specific lysine residues 
occurred before the formation of the pronucleus, despite the increase in global histone 
acetylation (Rybouchkin et al., 2006; Shi et al., 2008).  
The present study showed that the high levels of acetylation on H3K9/18/23 
were observed in the TSA-treated iSCNT group either at the PN or two-cell stage, 
which resembles the bovine IVF group in this study and is in agreement with previous 
studies in the mouse, sheep, cat and miniature pig (Gomez et al., 2011; Hou et al., 
2008; Yamanaka et al., 2009). The hyper-acetylation at several lysine residues of 
histone (H3K9/18/23) by TSA might promote the development of the blastocyst from 
an iSCNT embryo, as we reported previously (Wittayarat et al., 2013), because TSA 
would re-establish the embryonic epigenetic characteristics and gene expression 
within a limited time (PN to two-cell stage) (Shi et al., 2008; Wu et al., 2011) for an 
easier entry of some essential transcriptional factors into the nucleosome to activate 
gene expression (Lee et al., 1993; Yamanaka et al., 2009), stimulating more effective 
remodelling of the somatic chromatin (Rybouchkin et al., 2006). Subsequently, a 
decrease in the acetylation on each residue was observed after hyper-acetylation at the 
PN to the 2- or 4-cell stage. This gradual depletion of acetylation levels on 
H3K9/18/23 in the TSA-treated iSCNT and bovine IVF groups might have resulted 
from the dynamic change in GCN5, a ubiquitous histone acetyltransferase (Schiltz et 
al., 1999; Wu et al., 2010). High levels of GCN5 transcripts occur in the bovine 
germinal vesicle (GV), MII oocytes and two-cell stage embryos before markedly 
decreasing at the eight-cell stage (McGraw et al., 2003). The end point of TSA 
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treatment at 24 h may possibly inhibit the hyper-acetylation after development beyond 
the two-cell stage, resulting in the consistent decrease in acetylation levels with the 
dynamic change of GCN5; however, to understand the mechanism of the decrease in 
the acetylation levels, the assessment of GCN5 levels or other candidate molecule 
levels throughout embryonic development should be carried out.  
 The methylation of H3K9, catalysed by histone methyltransferases (HMTs) 
(Rice and Allis, 2001), generally correlates with transcriptional repression (Robin et 
al., 2007). Factors present in the recipient cytoplast are responsible for inducing de-
methylation of the transferred nucleus and the process is not species-specific (Gomez 
et al., 2011). We have observed that the H3K9me2 levels through early embryo 
development (2 h PF to PN stages) of the TSA-treated iSCNT embryos and bovine 
IVF embryos are apparently higher than that of the control embryos. Perhaps this 
phenomenon could be associated with the requirement for de-acetylation of H3K9 at 6 
h PF/PI. Methylation and acetylation of histone residues collaborate to control both 
gene transcription and repression, and the acetylation levels of histone residues is 
thought to be regulated by some sites of histone methylation (Rice and Allis, 2001). 
The de-acetylation of lysine 9 may serve to suppress transcriptionally competent 
regions of the genome by inducing methylation of lysine 9 and preventing the 
upstream assembly of heterochromatin (Rice and Allis, 2001). This suggests that, 
under TSA treatment, bovine cytoplasm was able to alter the de-methylation of 
chromatin in the cat donor cell to a sufficient level such that the de-acetylation could 
not occur at 6 h PF.         
 In conclusion, the treatment of iSCNT cat embryos with 50 nM TSA for 24 h 
after fusion provides beneficial effects regarding the modification of the acetylation 
levels of lysines 9, 18, 23 and the di-methylation level of lysine 9 on histone H3 in 
early embryogenesis, although the acetylation patterns may differ among the lysine 
residues. We suggest that the patterns of acetylation on H3K9/18/23 and di-
methylation on H3K9 induced by TSA in the present study were sufficient to resemble 
those of naturally fertilised embryos, leading to improvements in the in vitro 
development of iSCNT cat-cow embryos.  
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Fig. 1. Immunolocalisation of acetylation on H3K9 (H3K9ac) (A), H3K18 
(H3K18ac) (B), and H3K23 (H3K23ac) (C); dimethylation on H3K9 (H3K9me2) (D),  
and histone H3 (E) in the 2 h PF/PI, 6 h PF/PI, PN, 2-cell, 4-cell, and 8-cell stages of 
iSCNT cat embryos treated without (left, control) or with 50 nM TSA (middle) in 
comparison with in vitro fertilised bovine embryos (right). Each sample was 
counterstained with DAPI to visualise DNA. The pattern of H3K9/18/23ac and 
H3K9me2 were uniform between nuclei within the same embryo. Scale bar = 50 μm. 
 
Fig. 2. Relative intensity levels of acetylation on H3K9 (H3K9ac) (A), H3K18 
(H3K18ac) (B), H3K23 (H3K23ac) (C), di-methylation on H3K9 (H3K9me2) (D), 
and histone H3 (E) in the 2 h PF/PI, 6 h PF/PI, PN, 2-cell, 4-cell, and 8-cell stages of 
iSCNT cat embryos treated without or with 50 nM TSA in comparison to in vitro 
fertilised bovine embryos. Seven to ten iSCNT cat embryos with each staining were 
used to estimate the levels of H3K9/18/23ac, H3K9me2 and histone H3. Each bar 
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